Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 3 | 2024 | 114 | 1.920 |
Why?
|
| Smoking | 13 | 2026 | 1024 | 1.430 |
Why?
|
| Sexual Behavior | 11 | 2021 | 638 | 1.280 |
Why?
|
| Signal Transduction | 4 | 2024 | 2157 | 1.090 |
Why?
|
| Stress, Psychological | 4 | 2026 | 661 | 0.990 |
Why?
|
| Child Abuse | 6 | 2014 | 92 | 0.880 |
Why?
|
| Thermogenesis | 3 | 2021 | 26 | 0.840 |
Why?
|
| Hepatocytes | 1 | 2024 | 80 | 0.830 |
Why?
|
| Heterosexuality | 9 | 2021 | 97 | 0.810 |
Why?
|
| Fatty Liver | 1 | 2024 | 77 | 0.810 |
Why?
|
| Bisexuality | 8 | 2018 | 211 | 0.800 |
Why?
|
| Homosexuality, Female | 6 | 2018 | 60 | 0.770 |
Why?
|
| Gender Identity | 3 | 2021 | 117 | 0.760 |
Why?
|
| Liver | 1 | 2024 | 511 | 0.680 |
Why?
|
| Substance-Related Disorders | 5 | 2021 | 830 | 0.680 |
Why?
|
| Obesity | 7 | 2026 | 1151 | 0.630 |
Why?
|
| Longitudinal Studies | 13 | 2026 | 1063 | 0.560 |
Why?
|
| Adolescent | 25 | 2026 | 6081 | 0.530 |
Why?
|
| rho-Associated Kinases | 3 | 2025 | 36 | 0.520 |
Why?
|
| Acetylcholine | 3 | 2024 | 77 | 0.520 |
Why?
|
| Cell Communication | 1 | 2018 | 114 | 0.520 |
Why?
|
| Young Adult | 21 | 2026 | 5080 | 0.500 |
Why?
|
| Humans | 51 | 2026 | 43102 | 0.500 |
Why?
|
| Adult | 32 | 2026 | 13872 | 0.490 |
Why?
|
| Female | 41 | 2026 | 24698 | 0.470 |
Why?
|
| Socialization | 2 | 2026 | 23 | 0.460 |
Why?
|
| Body Mass Index | 5 | 2014 | 925 | 0.430 |
Why?
|
| Military Personnel | 2 | 2026 | 110 | 0.420 |
Why?
|
| United States | 18 | 2026 | 5205 | 0.390 |
Why?
|
| Suicide | 3 | 2023 | 140 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 1869 | 0.390 |
Why?
|
| Nurses | 5 | 2018 | 55 | 0.370 |
Why?
|
| Male | 26 | 2026 | 23409 | 0.370 |
Why?
|
| Restaurants | 3 | 2017 | 39 | 0.370 |
Why?
|
| Sex Offenses | 3 | 2012 | 45 | 0.360 |
Why?
|
| Telemedicine | 2 | 2026 | 234 | 0.360 |
Why?
|
| Spouse Abuse | 2 | 2012 | 52 | 0.350 |
Why?
|
| Alcohol Drinking | 3 | 2019 | 609 | 0.350 |
Why?
|
| Child | 16 | 2019 | 3443 | 0.340 |
Why?
|
| Domestic Violence | 1 | 2011 | 32 | 0.330 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 159 | 0.330 |
Why?
|
| Overweight | 2 | 2014 | 249 | 0.330 |
Why?
|
| Subcutaneous Fat | 2 | 2021 | 19 | 0.320 |
Why?
|
| Cohort Studies | 10 | 2019 | 1759 | 0.320 |
Why?
|
| Child Development | 1 | 2011 | 99 | 0.320 |
Why?
|
| Macrophages | 2 | 2024 | 529 | 0.290 |
Why?
|
| Mice, Knockout | 2 | 2024 | 1035 | 0.280 |
Why?
|
| Mice | 7 | 2025 | 6644 | 0.270 |
Why?
|
| Feasibility Studies | 2 | 2026 | 259 | 0.270 |
Why?
|
| Single-Parent Family | 1 | 2007 | 5 | 0.270 |
Why?
|
| Animals | 11 | 2026 | 16992 | 0.260 |
Why?
|
| Mental Health Services | 2 | 2026 | 141 | 0.260 |
Why?
|
| Parenting | 2 | 2007 | 137 | 0.250 |
Why?
|
| Alcoholism | 2 | 2021 | 305 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2015 | 1600 | 0.240 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2026 | 40 | 0.240 |
Why?
|
| Mothers | 2 | 2009 | 215 | 0.230 |
Why?
|
| Social Class | 2 | 2007 | 291 | 0.230 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 1596 | 0.230 |
Why?
|
| Casein Kinase II | 1 | 2025 | 17 | 0.230 |
Why?
|
| Women's Health | 2 | 2017 | 160 | 0.220 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2024 | 47 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2025 | 568 | 0.220 |
Why?
|
| Photosensitizing Agents | 1 | 2024 | 56 | 0.210 |
Why?
|
| Health Status | 2 | 2008 | 442 | 0.210 |
Why?
|
| Hydrogels | 1 | 2024 | 59 | 0.210 |
Why?
|
| Heart Rate | 1 | 2025 | 266 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1621 | 0.210 |
Why?
|
| Self Disclosure | 1 | 2004 | 44 | 0.200 |
Why?
|
| Sexuality | 2 | 2014 | 56 | 0.200 |
Why?
|
| Health Status Indicators | 1 | 2004 | 90 | 0.200 |
Why?
|
| Income | 1 | 2004 | 160 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2025 | 760 | 0.190 |
Why?
|
| Logistic Models | 4 | 2012 | 1009 | 0.190 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2023 | 70 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 760 | 0.180 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2021 | 36 | 0.180 |
Why?
|
| Choice Behavior | 3 | 2017 | 93 | 0.180 |
Why?
|
| Child Abuse, Sexual | 2 | 2012 | 22 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 19 | 0.180 |
Why?
|
| Risk Factors | 11 | 2019 | 3994 | 0.180 |
Why?
|
| Mental Disorders | 1 | 2026 | 392 | 0.170 |
Why?
|
| Poverty | 1 | 2004 | 400 | 0.170 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2020 | 1 | 0.160 |
Why?
|
| Time Factors | 4 | 2012 | 1857 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 497 | 0.160 |
Why?
|
| Health Promotion | 2 | 2017 | 704 | 0.160 |
Why?
|
| Creatine | 1 | 2020 | 10 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 35 | 0.160 |
Why?
|
| Body Image | 1 | 2021 | 89 | 0.160 |
Why?
|
| Age Factors | 5 | 2019 | 1154 | 0.160 |
Why?
|
| Adipokines | 1 | 2020 | 28 | 0.160 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 84 | 0.160 |
Why?
|
| Middle Aged | 12 | 2026 | 12222 | 0.160 |
Why?
|
| Lipoylation | 1 | 2019 | 17 | 0.150 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2010 | 26 | 0.150 |
Why?
|
| Family Relations | 1 | 2019 | 46 | 0.150 |
Why?
|
| Adipose Tissue, Brown | 1 | 2019 | 46 | 0.150 |
Why?
|
| Diet | 2 | 2016 | 826 | 0.150 |
Why?
|
| Commerce | 2 | 2017 | 95 | 0.140 |
Why?
|
| Prevalence | 6 | 2012 | 1612 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 213 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2019 | 469 | 0.140 |
Why?
|
| Adipogenesis | 1 | 2018 | 14 | 0.140 |
Why?
|
| Health Surveys | 3 | 2010 | 405 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2026 | 1001 | 0.140 |
Why?
|
| Anti-Obesity Agents | 1 | 2018 | 11 | 0.140 |
Why?
|
| Socioeconomic Factors | 4 | 2014 | 1234 | 0.130 |
Why?
|
| Adipocytes | 1 | 2018 | 60 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 193 | 0.130 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 5 | 0.130 |
Why?
|
| Carotid Artery, External | 1 | 2016 | 5 | 0.130 |
Why?
|
| Health Behavior | 3 | 2017 | 575 | 0.130 |
Why?
|
| Health Status Disparities | 3 | 2019 | 719 | 0.130 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 15 | 0.130 |
Why?
|
| Adenoviridae | 1 | 2016 | 62 | 0.130 |
Why?
|
| Diet Surveys | 1 | 2016 | 99 | 0.120 |
Why?
|
| Cell Line | 1 | 2020 | 1410 | 0.120 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 37 | 0.120 |
Why?
|
| Gene Transfer Techniques | 1 | 2016 | 53 | 0.120 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 420 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1019 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2016 | 165 | 0.120 |
Why?
|
| Adolescent Development | 1 | 2016 | 40 | 0.120 |
Why?
|
| Social Support | 2 | 2011 | 445 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 523 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 1067 | 0.110 |
Why?
|
| Neoplasms | 2 | 2024 | 1377 | 0.110 |
Why?
|
| Weight Gain | 2 | 2014 | 139 | 0.110 |
Why?
|
| Decision Making | 1 | 2016 | 249 | 0.100 |
Why?
|
| Trauma Severity Indices | 2 | 2012 | 31 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2016 | 587 | 0.090 |
Why?
|
| Confidence Intervals | 3 | 2011 | 162 | 0.090 |
Why?
|
| Violence | 1 | 2012 | 136 | 0.090 |
Why?
|
| Parent-Child Relations | 2 | 2016 | 127 | 0.090 |
Why?
|
| Exercise | 1 | 2017 | 692 | 0.090 |
Why?
|
| Research Design | 2 | 2022 | 385 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2012 | 195 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 539 | 0.080 |
Why?
|
| Health | 1 | 2010 | 30 | 0.080 |
Why?
|
| Self-Injurious Behavior | 1 | 2010 | 25 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2011 | 53 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2011 | 42 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2016 | 1546 | 0.080 |
Why?
|
| Minority Groups | 1 | 2014 | 690 | 0.070 |
Why?
|
| Massachusetts | 1 | 2008 | 35 | 0.070 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 749 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2020 | 140 | 0.070 |
Why?
|
| Censuses | 1 | 2007 | 28 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 56 | 0.070 |
Why?
|
| Survivors | 1 | 2008 | 152 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 518 | 0.060 |
Why?
|
| Naphthyridines | 1 | 2025 | 5 | 0.060 |
Why?
|
| Phenazines | 1 | 2025 | 6 | 0.060 |
Why?
|
| Psychometrics | 1 | 2007 | 358 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 85 | 0.050 |
Why?
|
| Asthma | 1 | 2009 | 416 | 0.050 |
Why?
|
| Saliva | 1 | 2025 | 119 | 0.050 |
Why?
|
| Wound Healing | 1 | 2024 | 88 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2004 | 126 | 0.050 |
Why?
|
| Quality of Life | 1 | 2008 | 616 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2024 | 408 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 694 | 0.050 |
Why?
|
| Muscles | 1 | 2022 | 82 | 0.050 |
Why?
|
| Incidence | 2 | 2018 | 1078 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3156 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2008 | 590 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 53 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2021 | 40 | 0.040 |
Why?
|
| Sexual Partners | 2 | 2016 | 326 | 0.040 |
Why?
|
| Infant | 1 | 2004 | 1175 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2008 | 2544 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 168 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2020 | 3 | 0.040 |
Why?
|
| Inflammation | 1 | 2026 | 758 | 0.040 |
Why?
|
| Adenine | 1 | 2020 | 46 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2020 | 44 | 0.040 |
Why?
|
| Risk | 2 | 2011 | 287 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2020 | 57 | 0.040 |
Why?
|
| Sex Factors | 2 | 2016 | 1028 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 118 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 257 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 187 | 0.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2018 | 7 | 0.030 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2018 | 14 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 26 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2019 | 490 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2018 | 18 | 0.030 |
Why?
|
| Menu Planning | 1 | 2017 | 8 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2019 | 452 | 0.030 |
Why?
|
| Aged | 3 | 2008 | 8214 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2018 | 55 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 28 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2019 | 258 | 0.030 |
Why?
|
| Marketing | 1 | 2017 | 45 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2676 | 0.030 |
Why?
|
| Amides | 1 | 2018 | 71 | 0.030 |
Why?
|
| Pyridines | 1 | 2018 | 139 | 0.030 |
Why?
|
| Rats, Inbred OLETF | 1 | 2016 | 5 | 0.030 |
Why?
|
| Incretins | 1 | 2016 | 2 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 51 | 0.030 |
Why?
|
| Homosexuality | 1 | 2016 | 36 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2016 | 42 | 0.030 |
Why?
|
| Venoms | 1 | 2016 | 18 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2019 | 574 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 704 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 91 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 238 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 207 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 532 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1766 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 638 | 0.030 |
Why?
|
| Self Concept | 1 | 2016 | 171 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2018 | 638 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 184 | 0.030 |
Why?
|
| California | 1 | 2016 | 548 | 0.030 |
Why?
|
| Aging | 1 | 2019 | 783 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 1772 | 0.030 |
Why?
|
| Depression | 1 | 2021 | 863 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 224 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1285 | 0.020 |
Why?
|
| Peptides | 1 | 2016 | 372 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 282 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 655 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1070 | 0.020 |
Why?
|
| Parents | 1 | 2016 | 370 | 0.020 |
Why?
|
| Rats | 1 | 2020 | 3735 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 114 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 440 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2011 | 55 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1455 | 0.020 |
Why?
|
| Death Certificates | 1 | 2010 | 15 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2010 | 141 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 247 | 0.020 |
Why?
|
| Chicago | 1 | 2009 | 31 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1568 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 250 | 0.020 |
Why?
|
| Nurse Clinicians | 1 | 2008 | 2 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 236 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 340 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 249 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2008 | 98 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 719 | 0.020 |
Why?
|
| Mexico | 1 | 2009 | 298 | 0.020 |
Why?
|
| Life Change Events | 1 | 2008 | 109 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 154 | 0.020 |
Why?
|
| Crime Victims | 1 | 2008 | 77 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2008 | 246 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 317 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 175 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2010 | 363 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 2012 | 486 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 167 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 737 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 835 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 734 | 0.010 |
Why?
|
| Mental Health | 1 | 2008 | 385 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 2853 | 0.010 |
Why?
|